Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis
NCT06788158Phase 1Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Sep 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of botulinum toxin type A in plantar fasciitis (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Visual Analogue Pain Scale at 16 weeks, Clinical Functional Status of the Ankle and Foot at 16 weeks and 2 more. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT06788158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06788158.